297 related articles for article (PubMed ID: 29293898)
1. Optogenetic termination of atrial fibrillation in mice.
Bruegmann T; Beiert T; Vogt CC; Schrickel JW; Sasse P
Cardiovasc Res; 2018 Apr; 114(5):713-723. PubMed ID: 29293898
[TBL] [Abstract][Full Text] [Related]
2. Optogenetic termination of atrial tachyarrhythmias by brief pulsed light stimulation.
Nakao M; Watanabe M; Miquerol L; Natsui H; Koizumi T; Kadosaka T; Koya T; Hagiwara H; Kamada R; Temma T; de Vries AAF; Anzai T
J Mol Cell Cardiol; 2023 May; 178():9-21. PubMed ID: 36965700
[TBL] [Abstract][Full Text] [Related]
3. Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models.
Boyle PM; Murphy MJ; Karathanos TV; Zahid S; Blake RC; Trayanova NA
J Physiol; 2018 Jan; 596(2):181-196. PubMed ID: 29193078
[TBL] [Abstract][Full Text] [Related]
4. Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes.
Bingen BO; Engels MC; Schalij MJ; Jangsangthong W; Neshati Z; Feola I; Ypey DL; Askar SF; Panfilov AV; Pijnappels DA; de Vries AA
Cardiovasc Res; 2014 Oct; 104(1):194-205. PubMed ID: 25082848
[TBL] [Abstract][Full Text] [Related]
5. The Connexin40A96S mutation from a patient with atrial fibrillation causes decreased atrial conduction velocities and sustained episodes of induced atrial fibrillation in mice.
Lübkemeier I; Andrié R; Lickfett L; Bosen F; Stöckigt F; Dobrowolski R; Draffehn AM; Fregeac J; Schultze JL; Bukauskas FF; Schrickel JW; Willecke K
J Mol Cell Cardiol; 2013 Dec; 65():19-32. PubMed ID: 24060583
[TBL] [Abstract][Full Text] [Related]
6. Light transmittance in human atrial tissue and transthoracic illumination in rats support translatability of optogenetic cardioversion of atrial fibrillation.
Nyns ECA; Portero V; Deng S; Jin T; Harlaar N; Bart CI; van Brakel TJ; Palmen M; Hjortnaes J; Ramkisoensing AA; Zhang GQ; Poelma RH; Ördög B; de Vries AAF; Pijnappels DA
J Intern Med; 2023 Sep; 294(3):347-357. PubMed ID: 37340835
[TBL] [Abstract][Full Text] [Related]
7. Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations.
Bruegmann T; Boyle PM; Vogt CC; Karathanos TV; Arevalo HJ; Fleischmann BK; Trayanova NA; Sasse P
J Clin Invest; 2016 Oct; 126(10):3894-3904. PubMed ID: 27617859
[TBL] [Abstract][Full Text] [Related]
8. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.
Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370
[TBL] [Abstract][Full Text] [Related]
9. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K
Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D
Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528
[TBL] [Abstract][Full Text] [Related]
10. Localized Optogenetic Targeting of Rotors in Atrial Cardiomyocyte Monolayers.
Feola I; Volkers L; Majumder R; Teplenin A; Schalij MJ; Panfilov AV; de Vries AAF; Pijnappels DA
Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29097406
[TBL] [Abstract][Full Text] [Related]
11. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K
Wiedmann F; Schulte JS; Gomes B; Zafeiriou MP; Ratte A; Rathjens F; Fehrmann E; Scholz B; Voigt N; Müller FU; Thomas D; Katus HA; Schmidt C
Basic Res Cardiol; 2018 Jun; 113(4):27. PubMed ID: 29881975
[TBL] [Abstract][Full Text] [Related]
13. Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management.
Nyns ECA; Kip A; Bart CI; Plomp JJ; Zeppenfeld K; Schalij MJ; de Vries AAF; Pijnappels DA
Eur Heart J; 2017 Jul; 38(27):2132-2136. PubMed ID: 28011703
[TBL] [Abstract][Full Text] [Related]
14. Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study.
Karathanos TV; Bayer JD; Wang D; Boyle PM; Trayanova NA
J Physiol; 2016 Dec; 594(23):6879-6891. PubMed ID: 26941055
[TBL] [Abstract][Full Text] [Related]
15. Relation of atrial refractoriness to upper and lower limits of vulnerability for atrial fibrillation/flutter following implantable ventricular defibrillator shocks.
Katz A; Sweeney RJ; Gill RM; Reid PR; Prystowsky EN
Circulation; 1999 Sep; 100(10):1125-30. PubMed ID: 10477539
[TBL] [Abstract][Full Text] [Related]
16. Systemic gene transfer enables optogenetic pacing of mouse hearts.
Vogt CC; Bruegmann T; Malan D; Ottersbach A; Roell W; Fleischmann BK; Sasse P
Cardiovasc Res; 2015 May; 106(2):338-43. PubMed ID: 25587047
[TBL] [Abstract][Full Text] [Related]
17. Chronic HDAC6 Activation Induces Atrial Fibrillation Through Atrial Electrical and Structural Remodeling in Transgenic Mice.
Sawa Y; Matsushita N; Sato S; Ishida N; Saito M; Sanbe A; Morino Y; Taira E; Obara M; Hirose M
Int Heart J; 2021; 62(3):616-626. PubMed ID: 34054002
[TBL] [Abstract][Full Text] [Related]
18. Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.
He Z; Sun C; Xu Y; Cheng D
Biomed Pharmacother; 2016 Dec; 84():1760-1767. PubMed ID: 27847200
[TBL] [Abstract][Full Text] [Related]
19. Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness.
Sticherling C; Oral H; Horrocks J; Chough SP; Baker RL; Kim MH; Wasmer K; Pelosi F; Knight BP; Michaud GF; Strickberger SA; Morady F
Circulation; 2000 Nov; 102(20):2503-8. PubMed ID: 11076824
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation and electrophysiology in transgenic mice with cardiac-restricted overexpression of FKBP12.
Pan Z; Ai T; Chang PC; Liu Y; Liu J; Maruyama M; Homsi M; Fishbein MC; Rubart M; Lin SF; Xiao D; Chen H; Chen PS; Shou W; Li BY
Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H371-H379. PubMed ID: 30499712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
